Evidence map›Paper›PMID 37227534›Full record

ReviewDiscover oncology2023

The interplay between N6-methyladenosine and precancerous liver disease: molecular functions and mechanisms.

Zhihua Lv, Ruoxi Ran, Yuting Yang, Meixian Xiang, Hanwen Su, Jingtao Huang

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Discover oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Multidimensional mechanisms of SFTSV-host interactions: viral protein functions, mFrontiers in cellular and infection microbiology · 2026
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Zhihua Lv *Department of Clinical Laboratory, Institute of Translational Medcine, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China.
Ruoxi Ran *Department of Clinical Laboratory, Institute of Translational Medcine, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China.
Yuting Yang *Department of General Office, School of Stomatology, Wuhan University, Wuhan, China.
Meixian XiangSchool of Pharmaceutical Sciences, South-Central University for Nationalities, Wuhan, China.
Hanwen SuDepartment of Clinical Laboratory, Institute of Translational Medcine, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China.
Jingtao HuangDepartment of Clinical Laboratory, Institute of Translational Medcine, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China. jthuang@whu.edu.cn.
Wuhan University · CNRenmin Hospital of Wuhan University · CNSouth Central Minzu University · CN

Funding

National Natural Science Foundation of China 81902141the Interdisciplinary Innovative Talents Foundation from Renmin Hospital of Wuhan University JCRCFZ-2022-023the Knowledge Innovation Program of Wuhan -Basic Research No.2022020201010402the Natural Science Foundation of Hubei Province 2022CFB127
6 · The paper itself

Abstract

N6-methyladenosine(m

Indexed as

CarcinogenesisLiver diseasem6AMolecular mechanisms

Identifiers

PMID37227534
PMCPMC10212880
OpenAlexW4378172344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.